MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q4
hinzugefügt 03.03.2026
Agilent Technologies Kurzfristige Verbindlichkeiten 2011-2026 | A
Kurzfristige Verbindlichkeiten Jährlich Agilent Technologies
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.71 B | 1.47 B | 2.08 B | 1.16 B | 1.26 B | 945 M | 976 M | 1.7 B | 1.6 B | 1.89 B | 1.84 B |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.08 B | 945 M | 1.51 B |
Kurzfristige Verbindlichkeiten anderer Aktien in der Diagnostik & Forschung
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Aspira Women's Health
AWH
|
3.46 M | - | -6.19 % | $ 10.5 M |  USA |
 |
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
22.9 M | $ 1.16 | -1.69 % | $ 6.32 M | USA |
 |
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
89.8 M | $ 16.69 | -6.86 % | $ 889 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M |  Britain |
 |
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | USA |
 |
Burning Rock Biotech Limited
BNR
|
372 M | $ 16.25 | 0.06 % | $ 175 M |  China |
 |
Exact Sciences Corporation
EXAS
|
641 M | - | - | $ 19.8 B | USA |
 |
Co-Diagnostics
CODX
|
3.54 M | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Accelerate Diagnostics
AXDX
|
66.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
49.4 M | $ 23.43 | -6.99 % | $ 651 M | USA |
 |
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | USA |
 |
Charles River Laboratories International
CRL
|
1.12 B | $ 175.55 | 0.27 % | $ 8.7 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | USA |
 |
Danaher Corporation
DHR
|
6.81 B | $ 192.99 | -1.63 % | $ 138 B | USA |
 |
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | USA |
 |
Interpace Biosciences
IDXG
|
5.1 M | $ 2.3 | 16.02 % | $ 10.2 M | USA |
 |
Illumina
ILMN
|
1.55 B | $ 123.67 | -3.38 % | $ 19.7 B | USA |
 |
Fulgent Genetics
FLGT
|
72.9 M | $ 15.02 | -5.12 % | $ 454 M | USA |
 |
Guardant Health
GH
|
303 M | $ 87.17 | -6.11 % | $ 10.9 B | USA |
 |
QIAGEN N.V.
QGEN
|
512 M | - | - | $ 10.6 B |  Niderland |
 |
Anixa Biosciences
ANIX
|
1.97 M | $ 2.74 | 0.37 % | $ 88.9 K | USA |
 |
Biomerica
BMRA
|
1.74 M | $ 2.2 | 2.33 % | $ 5.05 M | USA |
 |
ICON Public Limited Company
ICLR
|
2.8 B | $ 106.7 | 0.15 % | $ 8.8 B |  Irlanda |
 |
Check-Cap Ltd.
CHEK
|
1.81 M | - | - | $ 9.42 M |  Israel |
 |
Laboratory Corporation of America Holdings
LH
|
2.82 B | $ 273.26 | -0.53 % | $ 22.7 B | USA |
 |
Celcuity
CELC
|
44.2 M | $ 124.64 | 6.58 % | $ 5.83 B | USA |
 |
Medpace Holdings
MEDP
|
1.34 B | $ 501.5 | -3.68 % | $ 14.5 B | USA |
 |
Lantheus Holdings
LNTH
|
333 M | $ 81.43 | 1.75 % | $ 5.5 B | USA |
 |
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K | Israel |
 |
Myriad Genetics
MYGN
|
134 M | $ 4.44 | -6.92 % | $ 411 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.28 B | $ 197.82 | -0.5 % | $ 22 B | USA |
 |
NeoGenomics
NEO
|
88.3 M | $ 7.94 | -3.38 % | $ 1.02 B | USA |
 |
Neogen Corporation
NEOG
|
174 M | $ 10.04 | -2.95 % | $ 2.18 B | USA |
 |
ENDRA Life Sciences
NDRA
|
751 K | $ 5.31 | 2.71 % | $ 4.18 M | USA |
 |
National Research Corporation
NRC
|
36.6 M | $ 17.05 | -1.22 % | $ 382 M | USA |
 |
Natera
NTRA
|
310 M | $ 203.0 | -3.71 % | $ 20 B | USA |
 |
Invitae Corporation
NVTA
|
108 M | - | - | $ 21.2 M | USA |
 |
Organovo Holdings
ONVO
|
3.74 M | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
634 K | - | -16.95 % | $ 1.54 M | USA |